Ownership history in GLG LLC · 14 quarters on record
This page tracks every 13F SEC filing in which GLG LLC reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2017 Q3 | REDUCED | 6,327 | -589 | -8.5% | 0.18% | $2.8M | $444.12 |
| 2017 Q2 | ADDED | 6,916 | +1,987 | +40.3% | 0.21% | $3.4M | $487.84 |
| 2017 Q1 | ADDED | 4,929 | +749 | +17.9% | 0.11% | $1.9M | $384.91 |
| 2016 Q3 | REDUCED | 4,180 | -362 | -8.0% | 0.12% | $1.7M | $399.32 |
| 2016 Q2 | REDUCED | 4,542 | -750 | -14.2% | 0.12% | $1.6M | $346.89 |
| 2016 Q1 | REDUCED | 5,292 | -834 | -13.6% | 0.12% | $1.9M | $358.02 |
| 2015 Q4 | ADDED | 6,126 | +5,201 | +562.3% | 0.20% | $3.3M | $539.23 |
| 2015 Q3 | REDUCED | 925 | -13 | -1.4% | 0.01% | $430K | $462.02 |
| 2015 Q2 | REDUCED | 938 | -104 | -10.0% | 0.01% | $479K | $506.71 |
| 2015 Q1 | ADDED | 1,042 | +796 | +323.6% | 0.01% | $470K | $448.45 |
As of 2025 Q4 — sorted by position size